Baert J L, Monté D, Musgrove E A, Albagli O, Sutherland R L, de Launoit Y
Unité d'Oncologie Moléculaire, CNRS URA 1160, Institut Pasteur de Lille, France.
Int J Cancer. 1997 Mar 4;70(5):590-7. doi: 10.1002/(sici)1097-0215(19970304)70:5<590::aid-ijc17>3.0.co;2-h.
The PEA3 group of transcription factors belongs to the ets family and is composed of 3 known members, PEA3, ERM and ER81, which are more than 95% identical within the DNA-binding ETS domain and exhibit 50% aa identity overall. Recently, transgenic mice bearing the c-erbB-2/neu oncogene have been shown to over-express PEA3 mRNA in mammary adenocarcinomas, suggesting a role for this gene family in mammary tumorigenesis. In the present work we characterized the mRNA expression levels of PEA3-group genes in a series of human epithelial breast cell lines. Each of the 3 genes was highly expressed in normal human HMEC 1001-7 and HMEC 219-4 cells. In breast-cancer cell lines, the 3 genes were highly expressed in the ER- MDA-MB-436, MDA-MB-330, MDA-MB-231 and BT-20 cell lines, but not in the ER+ MDA-MB-134-VI and ZR-75-1 cells. In an attempt to characterize the PEA3-group proteins in breast-cancer cells, we first produced and characterized specific antibodies against each of these 3 proteins. The anti-ERM and anti-ER81 antibodies recognized specific strong bands at approximately 72 kDa and 62 kDa, corresponding to ERM and ER81, respectively, in MDA-MB-231 and Hs-578T cells expressing significant levels of the 3 mRNAs. No protein was detected in MCF-7 cells expressing low levels of mRNA for PEA3-group-family genes, or in ZR-75-1 cells, where mRNA was undetectable by Northern blot. Although in vitro-translated PEA3 is specifically immunoprecipitated by anti-PEA3 anti-serum, we were unable to immunoprecipitate PEA3 protein from MDA-MB-231 and Hs-578T cells. In order to study the transcription factor activity of ERM, PEA3 and ER81 proteins in mammary-cancer cells, we tested their ability to transactivate a reporter plasmid containing 3 Ets-binding sites, and were able to show that, in all the breast-cancer cells tested, transfected ERM, PEA3 and ER81 are able to transactivate. Although the target genes of the PEA3 group of transcription factors in breast-cancer cells have yet to be determined, these genes have a potential role in the regulation of growth and the progression of human breast cancer.
转录因子PEA3家族属于ets家族,由3个已知成员组成,即PEA3、ERM和ER81,它们在DNA结合ETS结构域内的同源性超过95%,总体氨基酸同源性为50%。最近研究表明,携带c-erbB-2/neu癌基因的转基因小鼠在乳腺腺癌中过度表达PEA3 mRNA,提示该基因家族在乳腺肿瘤发生中起作用。在本研究中,我们对一系列人乳腺上皮细胞系中PEA3家族基因的mRNA表达水平进行了鉴定。这3个基因在正常人HMEC 1001-7和HMEC 219-4细胞中均高表达。在乳腺癌细胞系中,这3个基因在雌激素受体(ER)阴性的MDA-MB-436、MDA-MB-330、MDA-MB-231和BT-20细胞系中高表达,但在ER阳性的MDA-MB-134-VI和ZR-75-1细胞中不表达。为了鉴定乳腺癌细胞中的PEA3家族蛋白,我们首先制备并鉴定了针对这3种蛋白的特异性抗体。抗ERM和抗ER81抗体在表达高水平这3种mRNA的MDA-MB-231和Hs-578T细胞中分别识别出大约72 kDa和62 kDa的特异性强条带,分别对应于ERM和ER81。在表达低水平PEA3家族基因mRNA的MCF-7细胞或通过Northern印迹检测不到mRNA的ZR-75-1细胞中未检测到蛋白。尽管体外翻译的PEA3能被抗PEA3抗血清特异性免疫沉淀,但我们无法从MDA-MB-231和Hs-578T细胞中免疫沉淀出PEA3蛋白。为了研究ERM、PEA3和ER81蛋白在乳腺癌细胞中的转录因子活性,我们检测了它们激活含有3个Ets结合位点的报告质粒的能力,结果表明,在所有检测的乳腺癌细胞中,转染的ERM、PEA3和ER81都能够激活该质粒。尽管乳腺癌细胞中转录因子PEA3家族的靶基因尚未确定,但这些基因在人类乳腺癌的生长和进展调控中具有潜在作用。